Oral albendazole in the management of extraocular cysticercosis.
AUTOR(ES)
Sihota, R
RESUMO
Surgical removal of extraocular cysticerci is fraught with complications. The effect of oral albendazole in such cases has been evaluated in a randomised, controlled, clinical trial. Of 24 ultrasonographically diagnosed, and ELISA positive cases of extraocular cysticerci, 12 received oral albendazole 15 mg/kg once daily for 1 month, while the 12 controls received a placebo. Marked clinical improvement was seen in all the cases in the treatment group at 4 weeks, with collapse of the cyst at 6 weeks (75%), and complete disappearance at 3 months (100%). No clinical or ultrasonographical change was noted in the control group. A trial of medical management with oral albendazole merits consideration in cases of extraocular cysticerci.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=504887Documentos Relacionados
- Granuloma cytokines in murine cysticercosis.
- Immunoglobulin E and G4 antibodies in cysticercosis.
- Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.
- Selective indications for the use of praziquantel in the treatment of brain cysticercosis.
- Evaluation of enzyme-linked immunoassay for serological diagnosis of cysticercosis.